![]() |
|||||||
|
Select Publications Bianco FJ et al. Influence of the surgeon on cancer control after radical prostatectomy. Prostate Cancer Symposium 2006;Abstract 272. Bill-Axelson A et al; Scandinavian Prostate Cancer Group Study No. 4. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2005;352(19):1977-84. Abstract D’Amico AV et al. Prostate specific antigen doubling time as a surrogate end point for prostate cancer specific mortality following radical prostatectomy or radiation therapy. J Urol 2004;172(5 Pt 2):42-6. Abstract Glode LM et al. SWOG 9921 - A phase III multi-institutional trial of adjuvant therapy for high risk prostate cancer after radical prostatectomy. Proc ASCO Prostate Cancer Symposium 2007;Abstract 349. Labrie F et al. Gonadotropin-releasing hormone agonists in the treatment of prostate cancer. Endocr Rev 2005;26(3):361-79. Abstract |
Editor INTERVIEWS Eric A Klein, MD Anthony V D’Amico, MD, PhD Nicholas J Vogelzang, MD
|